Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) GLRA1 Antibodies:
anti-Human GLRA1 Antibodies:
anti-Mouse (Murine) GLRA1 Antibodies:
Go to our pre-filtered search.
Mouse (Murine) Polyclonal GLRA1 Primary Antibody for ELISA, WB - ABIN4314751
Wang, Lynch: Activation and desensitization induce distinct conformational changes at the extracellular-transmembrane domain interface of the glycine receptor. in The Journal of biological chemistry 2011
The E103K startle mutation reduces the sensitivity of glycine receptor alpha 1 to both glycine and sarcosine and impairs channel gating.
gain-of-function GLRA1 mutations also cause hyperekplexia, although the mechanism is unknown. Here we identify two new gain-of-function mutations (I43F and W170S) and characterize these along with known gain-of-function mutations (Q226E, V280M, and R414H) to identify how they cause hyperekplexia.
GLRA1 and GLRB (show GLRB Antibodies) mutations are responsible for abnormal startled reactions in humans. (Review)
in two sisters with hyperekplexia a compound heterozygosis of 2 novel mutations of GLRA1 gene was found - heterozygous for a C-to-G base transition resulting in a phenylalanine to leucine amino acid change in position 235 and for a T-to-C base transition resulting in a cysteine to arginine amino acid change in position 237
the TM3 (show TPM1 Antibodies)-4 loop length is critical for glycine receptor (show GLRB Antibodies) alpha1 desensitization and a direct neighborhood of both basic stretches changes receptor properties from non-desensitizing to desensitizing.
Mutations in the GLRA1 were identified in 16 Japanese patients with hyperekplexia.
The first X-ray structure of the TMD (show TTN Antibodies) of the alpha1GlyR solved here using GLIC as a scaffold paves the way for mechanistic investigation and design of allosteric modulators of a human receptor.
In GlyRA1 mutants, a portion of them can be transported to the plasma membrane but don't form funtional channels; a possible cause for hyperekplexia.
Conformation and function of the human GLRA1 chloride channel (show CLCA1 Antibodies).
Analysis of hyperekplexia mutations identifies transmembrane domain rearrangements that mediate glycine receptor (show GLRB Antibodies) activation.
The results of this study suggested that the Glra1 activation can regulate receptor diffusion and cluster size at inhibitory synapses in mature stage, providing not only new insights into the postsynaptic mechanism of shifting inhibitory neurotransmission but also the inhibitory synaptic plasticity in mature nervous system
Glra1 receptor Beta8-Beta9 loop is an essential regulator of conformational rearrangements in ion channel opening and closing.
Mutation of a zinc-binding residue in the glycine receptor (show GLRB Antibodies) alpha1 changes ethanol sensitivity in vitro and alcohol consumption in Glra1(D80A) knock-in mice.
TM3 (show TPM1 Antibodies)-4 loop subdomains are important for functional reconstitution of glycine receptors by independent domains
Mutations in the GlyR alpha-1 subunit, M287L and Q266I, resulted in a small but general impairment of glycine action, that is most evident in the glycine-induced maximal currents.
Mutations in the GlyR alpha-1 subunit, M287L and Q266I, decreased specific behavioral actions of ethanol and altered other nonethanol behaviors, demonstrating the importance of GlyR function in diverse neuronal systems.
The values of breathing frequency, tidal volume, and minute ventilation in newborn Glra1-deficient oscillator mice decrease rapidly during postnatal development.
The new Glra1 mutation appears to affect glycine's inhibitory neurotransmission in the central nervous system (CNS) of the nmf11 homozygotes, which suffer from a severe startle disease-related phenotype and die by postnatal day 21.
Thus, the hyperekplexia phenotype of Glra1(D80A) mice is due to the loss of Zn(2+) potentiation of alpha1 subunit containing GlyRs (show GARS Antibodies), indicating that synaptic Zn(2+) is essential for proper in vivo functioning of glycinergic neurotransmission.
These results show that insulin (show INS Antibodies) has a novel regulatory action on the potency of glycine for ionotropic glycine receptors.
The protein encoded by this gene is a subunit of a pentameric inhibitory glycine receptor. The receptor mediates postsynaptic inhibition in the central nervous system. Defects in this gene are a cause of startle disease (STHE), also known as hereditary hyperekplexia or congenital stiff-person syndrome. Two transcript variants encoding different isoforms have been found for this gene.
glycine receptor, alpha 1 (startle disease/hyperekplexia)
, glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome)
, glycine receptor, alpha 1
, glycine receptor subunit alpha-1-like
, glycine receptor 48 kDa subunit
, glycine receptor strychnine-binding subunit
, glycine receptor subunit alpha-1
, glycine receptor, alpha 1 subunit
, GlyR [a]Z1
, glycine receptor subunit alphaZ1
, glycine receptor, alphaZ1 subunit
, glycine receptor alpha 1 subunit